AgaMatrix Wavesense Presto
The technology used in the AgaMatrix Wavesense Presto, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★ Recommendation||Recent clinical validation; older protocol|
|Institute of Health Economics (CA)||General use||No evidence provided|
Brazg RL, Klaff LJ, Parkin CG. Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers. J Diabetes Sci Technol. 2013 Jan 1;7(1):144-52. doi: 10.1177/193229681300700117. PMID: 23439170. Available from: PMC3692226.
15197:2003 - Pass General population